Add BrightSurf on Google Email

Science News for March 25, 2023


Is early rhythm control in atrial fibrillation care cost-effective?

A study analyzed the EAST – AFNET 4 trial, finding early rhythm control therapy improves outcomes in patients with AF and comorbidities. However, a cost-effectiveness analysis revealed that the health benefits come at reasonable additional costs.

SourceEuropean Society of Cardiology·JournalEP Europace·TypeObservational study·DateMar 25, 2023

The heart benefits of walnuts likely come from the gut

A new study found that eating walnuts may alter the mix of gut microbes in a way that increases the body's production of amino acid L-homoarginine, which has been linked to lower cardiovascular risk. Researchers also discovered higher levels of certain bacteria in the gut of participants on the walnut diet.

SourceAmerican Society for Biochemistry and Molecular Biology·DateMar 25, 2023
CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

Ammonia: Efficient hydrogen carrier and green steel enabler

Researchers at Max Planck Institute developed an ammonia-based direct reduction process to produce sustainable iron and steel, overcoming logistics and energetic disadvantages of hydrogen. The process yields the same metallization degree as hydrogen-based reduction while forming nitrides that protect the sponge iron from corrosion.

SourceMax-Planck-Gesellschaft·JournalAdvanced Science·TypeExperimental study·DateMar 25, 2023

The utilization of atezolizumab as a primer for chemoradiation results in promising immune system alterations for women with locally advanced cervical cancer

The NRG-GY017 trial found that atezolizumab improved 2-year disease-free survival rates (79% vs. 59%) and pathologically complete or partial responses (69% vs. 40%) for patients with locally advanced cervical cancer. The study also showed a favorable immune response, including positive PD-L1 scoring and T-cell receptor clonal expansion.

SourceNRG Oncology·DateMar 25, 2023

The more traumatic the childhood, the angrier the adult

Researchers have found that depression and anxiety sufferers who experienced traumatic childhoods tend to grow up as angry adults. The severity of childhood trauma is also correlated with the level of adult anger, with emotional neglect increasing irritability and physical abuse leading to anger attacks or antisocial personality traits.

SourceEuropean Psychiatric Association·DateMar 25, 2023
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

The addition of gemcitabine with cisplatin and intensity-modulated radiation therapy improves outcomes for women with locally advanced vulvar cancer

Women with locally advanced squamous cell carcinoma of the vulva who received gemcitabine concurrently with cisplatin and intensity-modulated radiation therapy exhibited increased rates of pathologic complete responses. The study found improved survival and response outcomes for this population, while minimizing toxicity.

SourceNRG Oncology·DateMar 25, 2023

The GOG Foundation, Inc. (GOG) announced positive results from an investigator-initiated phase II trial, sponsored by the GOG, investigating the combination of ribociclib and letrozole in patients with recurrent low-grade serous ovarian cancer (LGSOC) (GO

A phase II trial investigating the combination of ribociclib and letrozole showed a response rate of 23%, progression-free survival of 19.1 months, and duration of response of 19.1 months in patients with recurrent low-grade serous ovarian cancer.

SourceThe GOG Foundation Inc·TypeRandomized controlled/clinical trial·DateMar 25, 2023